Hyderabad has transformed into a global hub for life sciences manufacturing, gaining recognition for its contribution to pharmaceutical production, vaccine manufacturing, and life sciences research. Known as the “Vaccine Capital of the World,” Hyderabad is home to Genome Valley, a leading biotech cluster hosting over 200 biotech and pharmaceutical companies. This thriving ecosystem has attracted major players in the industry, making Hyderabad a dominant force in India’s life sciences sector.
Genesis of Genome Valley: A Biotech Breakthrough in Hyderabad
Hyderabad’s journey as a life sciences leader began with the establishment of Genome Valley, a dedicated biotech cluster that quickly became India’s most significant hub for pharmaceutical and biotech industries. Launched as a public-private partnership, Genome Valley hosts over 200 companies, including global leaders in research and development (R&D). The region offers world-class facilities for research, training, and large-scale manufacturing.
- Over 200 biotech companies from 18 countries
- Six of the world’s top 10 R&D firms have a presence
- Offers specialized infrastructure for biopharma, medical devices, and research
Hyderabad’s Dominance in India’s Pharma and Vaccine Output:
Hyderabad contributes nearly one-third of India’s pharmaceutical production and accounts for one-third of the world’s vaccine output. This dominance is fueled by a combination of world-class research facilities, skilled talent, and strong industry partnerships.
- 33% of India’s pharmaceutical production
- 20% of India’s pharmaceutical exports
- 33% of global vaccine production
One-Third of the World’s Vaccine Output is in Hyderabad:
Hyderabad’s reputation as the “Vaccine Capital of the World” is well-earned. Major vaccine manufacturers like Bharat Biotech, Biological E, and Indian Immunologicals have established large-scale production facilities in the city, making it a critical player in global healthcare.
- Bharat Biotech and Biological E are key players
- Hyderabad’s vaccine production capacity supports global immunization efforts
- Government support and favorable policies drive industry growth
5.8 Million sq. ft. of New Innovation Space in Hyderabad:
Hyderabad’s life sciences industry has also triggered a real estate boom. In 2025, the gross office leasing space for life sciences companies surged by 56%, adding 5.8 million square feet of new innovation space. This rapid expansion is a testament to the city’s growing importance as a life sciences hub.
- 5.8 million sq. ft. of new innovation space leased in 2025
- Life sciences firms account for a major share of this expansion
- World-class lab and research facilities attract global companies
Hyderabad vs. Global Hubs: Competing with Boston, Shanghai, and Tokyo
Hyderabad has emerged as a formidable competitor to global life sciences hubs such as Boston, Shanghai, and Tokyo. With its rapidly expanding biotech ecosystem, skilled workforce, and supportive government policies, Hyderabad is now a preferred destination for life sciences investments.
- Competes with Boston, Shanghai, and Tokyo for life sciences R&D
- Attracts international biotech companies
- Strategic location with access to global markets
Top Companies Operating in Hyderabad’s Life Sciences Ecosystem:
Hyderabad is home to some of the world’s leading life sciences companies. These organizations drive innovation, research, and large-scale manufacturing, making the city a powerhouse in the global biotech landscape.
- Bharat Biotech, a global leader in vaccines
- Biological E, a prominent vaccine and pharmaceutical manufacturer
- Novartis and Sai Life Sciences with major R&D operations
Government Boost: Telangana’s 2023–2028 Life Sciences Policy
The Telangana government has played a pivotal role in fostering Hyderabad’s life sciences sector. The 2023–2028 Life Sciences Policy provides fiscal incentives, world-class infrastructure, and public-private partnerships to attract investments.
- Offers fiscal incentives for biotech companies
- Ready-to-use infrastructure in Genome Valley and Pharma City
- Strategic public-private partnerships to boost growth
Hyderabad Pharma City: Blueprint for the World’s Largest Pharma Cluster
Hyderabad Pharma City is an ambitious project designed to be the world’s largest integrated pharma cluster. Spread over 19,000 acres, it offers specialized zones for manufacturing, research, and logistics, making it a one-stop destination for life sciences.
- 19,000-acre integrated pharma cluster
- Dedicated zones for R&D, manufacturing, and logistics
- Expected to attract significant global investments
Infrastructure: Why Global Giants Choose Hyderabad?
Hyderabad’s advanced infrastructure, including specialized labs, innovation hubs, and efficient logistics, makes it a preferred destination for global life sciences companies.
- World-class laboratory facilities and research centers
- Genome Valley and Pharma City offer plug-and-play infrastructure
- Efficient connectivity to international markets
Conclusion:
Hyderabad’s rise as a global hub for life sciences manufacturing is a testament to its world-class infrastructure, skilled talent, and proactive government policies. As the city continues to grow, it is poised to become a key player in the global life sciences industry.
FAQs:
Hyderabad is known for its robust life sciences ecosystem, featuring Genome Valley, leading biotech firms, and extensive vaccine manufacturing capabilities.
Companies like Bharat Biotech, Biological E, Indian Immunologicals, Sai Life Sciences, and Novartis operate in Hyderabad.
Hyderabad produces approximately one-third of the world’s vaccines.
Skilled talent, foreign direct investment, cost-effective manufacturing, and government support.
Yes, with ongoing government support, increasing FDI, and global demand for life sciences products, Hyderabad is expected to continue its rapid growth.